Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that ...
Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that could help medical professionals better target and treat cancer.
Approximately 90% of patients diagnosed with endometrial cancer present with complaints ... In the evaluation of retroperitoneal lymph node metastasis, FDG-PET could only detect metastatic lesions ...
A recent study found that fluorodeoxyglucose positron emission tomography/computed tomography ([18F] FDG PET/CT) was better ...
This drug approval followed the publication of the EMBARK trial, a randomized phase III trial of biochemically recurrent patients who had high-risk disease, defined by a PSA doubling time (PSADT) ≤9 ...
From Gerry Turner announcing he has cancer to the return of a Chicago Cubs legend’s disease, here’s what’s happening in the ...
He says PET scans are essential for lung cancer diagnoses compared to other ... they are particularly effective at identifying metastatic disease. However, PET/CT interpretation is complex and ...
Dr Michelle Melisko discusses the challenging aspects involved in decision-making around screening for brain metastasis in ...
The authors at King’s College London say that using the radiotracer – an injected compound used in PET scans – could help inform doctors that a patients aggressive cancer will not respond to ...